1. 2020
  2. Inhibitory activity against carbonic anhydrase IX and XII as a candidate selection criterion in the development of new anticancer agents

    Krasavin, M., Kalinin, S., Sharonova, T. & Supuran, C. T., 1 Jan 2020, In: Journal of Enzyme Inhibition and Medicinal Chemistry. 35, 1, p. 1555-1561 7 p.

    Research output: Contribution to journalArticlepeer-review

  3. Screening of benzenesulfonamide in combination with chemically diverse fragments against carbonic anhydrase by differential scanning fluorimetry

    Krasavin, M., Kalinin, S., Zozulya, S., Gryniukova, A., Borysko, P., Angeli, A. & Supuran, C. T., 1 Jan 2020, In: Journal of Enzyme Inhibition and Medicinal Chemistry. 35, 1, p. 306-310 5 p.

    Research output: Contribution to journalArticlepeer-review

  4. Combining carbonic anhydrase and thioredoxin reductase inhibitory motifs within a single molecule dramatically increases its cytotoxicity

    Krasavin, M., Sharonova, T., Sharoyko, V., Zhukovsky, D., Kalinin, S., Žalubovskis, R., Tennikova, T. & Supuran, C. T., 2020, In: Journal of Enzyme Inhibition and Medicinal Chemistry. 35, 1, p. 665-671 7 p.

    Research output: Contribution to journalArticlepeer-review

  5. 2019
  6. From random to rational: A discovery approach to selective subnanomolar inhibitors of human carbonic anhydrase IV based on the Castagnoli-Cushman multicomponent reaction

    Kalinin, S., Nocentini, A., Kovalenko, A., Sharoyko, V., Bonardi, A., Angeli, A., Gratteri, P., Tennikova, T. B., Supuran, C. T. & Krasavin, M., 15 Nov 2019, In: European Journal of Medicinal Chemistry. 182, 18 p., 111642.

    Research output: Contribution to journalArticlepeer-review

  7. Highly hydrophilic 1,3-oxazol-5-yl benzenesulfonamide inhibitors of carbonic anhydrase II for reduction of glaucoma-related intraocular pressure

    Kalinin, S., Valtari, A., Ruponen, M., Toropainen, E., Kovalenko, A., Nocentini, A., Gureev, M., Dar'in, D., Urtti, A., Supuran, C. T. & Krasavin, M., 1 Nov 2019, In: Bioorganic and Medicinal Chemistry. 27, 21, 8 p., 115086.

    Research output: Contribution to journalArticlepeer-review

  8. Pyridazinone-substituted benzenesulfonamides display potent inhibition of membrane-bound human carbonic anhydrase IX and promising antiproliferative activity against cancer cell lines

    Krasavin, M., Shetnev, A., Baykov, S., Kalinin, S., Nocentini, A., Sharoyko, V., Poli, G., Tuccinardi, T., Korsakov, M., Tennikova, T. B. & Supuran, C. T., 15 Apr 2019, In: European Journal of Medicinal Chemistry. 168, p. 301-314 14 p.

    Research output: Contribution to journalArticlepeer-review

  9. 1,2,4-Oxadiazole/2-Imidazoline Hybrids: Multi-target-directed Compounds for the Treatment of Infectious Diseases and Cancer

    Shetnev, A., Baykov, S., Kalinin, S., Belova, A., Sharoyko, V., Rozhkov, A., Zelenkov, L., Tarasenko, M., Sadykov, E., Korsakov, M. & Krasavin, M., 1 Apr 2019, In: International Journal of Molecular Sciences. 20, 7, p. 1699 10 p., 1699.

    Research output: Contribution to journalArticlepeer-review

  10. Continued exploration of 1,2,4-oxadiazole periphery for carbonic anhydrase-targeting primary arene sulfonamides: Discovery of subnanomolar inhibitors of membrane-bound hCA IX isoform that selectively kill cancer cells in hypoxic environment

    Krasavin, M., Shetnev, A., Sharonova, T., Baykov, S., Kalinin, S., Nocentini, A., Sharoyko, V., Poli, G., Tuccinardi, T., Presnukhina, S., Tennikova, T. B. & Supuran, C. T., 15 Feb 2019, In: European Journal of Medicinal Chemistry. 164, p. 92-105

    Research output: Contribution to journalArticlepeer-review

  11. 2018
  12. Heterocyclic periphery in the design of carbonic anhydrase inhibitors: 1,2,4-Oxadiazol-5-yl benzenesulfonamides as potent and selective inhibitors of cytosolic hCA II and membrane-bound hCA IX isoforms

    Krasavin, M., Shetnev, A., Sharonova, T., Baykov, S., Tuccinardi, T., Kalinin, S., Angeli, A. & Supuran, C. T., 1 Feb 2018, In: Bioorganic Chemistry. 76, p. 88-97 10 p.

    Research output: Contribution to journalArticlepeer-review

  13. Unprotected primary sulfonamide group facilitates ring-forming cascade en route to polycyclic [1,4]oxazepine-based carbonic anhydrase inhibitors

    Sapegin, A., Kalinin, S., Angeli, A., Supuran, C. T. & Krasavin, M., 1 Feb 2018, In: Bioorganic Chemistry. 76, p. 140-146 7 p.

    Research output: Contribution to journalArticlepeer-review

ID: 35258413